Showing 181 - 200 results of 2,085 for search '"Viral hepatitis"', query time: 0.10s Refine Results
  1. 181
  2. 182
  3. 183

    The Changing Epidemiology of Viral Hepatitis in a Post-Soviet Country—The Case of Kyrgyzstan by Manas K. Akmatov, Nurgul J. Beisheeva, Asylbek Z. Nurmatov, Sattarova J. Gulsunai, Kylychbekova N. Saikal, Aisuluu A. Derkenbaeva, Zamira O. Abdrahmanova, Jana Prokein, Norman Klopp, Thomas Illig, Omor T. Kasymov, Zuridin S. Nurmatov, Frank Pessler

    Published 2023-07-01
    “…Historically, viral hepatitis has been a considerable public health problem in Central Asian countries, which may have worsened after the dissolution of the Soviet Union. …”
    Get full text
    Article
  4. 184
  5. 185

    Viral Hepatitis Markers in Antepartum and Postpartum Women in Rio de Janeiro, Brazil by Lia Laura Lewis-Ximenez, Ana Maria Coimbra Gaspar, Antonio Carlos Cavalieri D'Oro, Luiz Antonio Chilelli Mercadante, Cleber Ferreira Ginuino, Clara Fumiko Tachibana Yoshida

    Published 2002-03-01
    “…A seroprevalence study was carried out among a group of women in Rio de Janeiro to determine the prevalence of different markers for viral hepatitis given the limited data among healthy populations. …”
    Get full text
    Article
  6. 186
  7. 187

    The significance of the detoxification system disorders in fibrogenesis in Chronic Viral Hepatitis С in children by E. A. Galova, V. V. Krasnov

    Published 2021-07-01
    “…Aim: to determine the relationship between of levels»protoxic» metabolites and «profibrotic» metabolites in the blood serum in children with chronic viral hepatitis C (HCV).Material and methods: the authors examined 54 children 14.0[6,0] years old with HCV. …”
    Get full text
    Article
  8. 188
  9. 189

    Specific CD8+ T cell response immunotherapy for hepatocellular carcinoma and viral hepatitis by Moreno-Cubero, E, Larrubia, J

    Published 2016
    “…The humanized monoclonal antibodies against CTLA-4 (tremelimumab and ipilimumab) and PD-1 (nivolumab and pembrolizumab) have yielded good results in testing of HCC and chronic viral hepatitis patients. Trelimumab, in particular, has shown a significant increase in the time to progression in HCC, while nivolumab has shown a remarkable effect on hepatitis C viral load reduction. …”
    Journal article
  10. 190
  11. 191
  12. 192
  13. 193

    Clinic-epidemiologic characteristic of viral hepatitis B in children in the Tomsk Region (1994—2009) by S. B. Korobeinikova, K. I. Chuikova, L. L. Katanakhova

    Published 2011-08-01
    “…The problem of parenteral viral hepatitis, in particular, viral hepatitis B (VHB), is urgent till now owing to some social, economic, and epidemiologic factors. …”
    Get full text
    Article
  14. 194
  15. 195
  16. 196
  17. 197
  18. 198

    The prevalence of serological markers of viral hepatitis among labor migrants arriving in the Russian Federation by N. D. AlSalih, D. A. Sychev, I. A. Potemkin, K. K. Kyuregyan, M. I. Mikhailov

    Published 2017-06-01
    “…To determine of the prevalence of viral hepatitis A, E, B, C and D markers in migrant workers.Materials and methods. …”
    Get full text
    Article
  19. 199

    Chronic Viral Hepatitis in the Italian Prison Setting: Prevalence, Outcomes, Literature Needs and Perspectives by Vito Fiore, Andrea De Vito, Emanuele Pontali, Luciano Lucania, Giordano Madeddu, Sergio Babudieri

    Published 2021-09-01
    “…Compared with the general population, incarcerated people have a higher prevalence of several communicable diseases, including viral hepatitis. Nevertheless, there is still a lack of literature in field. …”
    Get full text
    Article
  20. 200